Search research articles
Contact Us
Filters
Showing results (1-10 of 145) with videos related to
Page
of 15
Sort By:
The Journal of Urology
|
January 19, 2022
Editorial Comment
Scott Eggener
The Journal of Urology
|
February 22, 2011
Editorial comment
Scott Eggener
European Urology
|
September 19, 2015
Prostate Cancer Screening Biomarkers: An Emerging Embarrassment of 'Riches'?
Scott Eggener
Urologic Oncology
|
August 5, 2014
Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005
Scott Eggener
BJU International
|
January 22, 2015
How active should active surveillance be?
Scott Eggener
The Canadian Journal of Urology
|
June 19, 2012
Re: Active surveillance failure for prostate cancer: does the delay in treatment increase the risk of urinary incontinence?
Scott Eggener
European Urology
|
July 22, 2008
Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
Scott Eggener
European Urology Focus
|
July 21, 2017
Known Knowns, Known Unknowns, and Unknown Unknowns of High-intensity Focused Ultrasound for Prostate Cancer
Scott Eggener
European Urology Focus
|
November 28, 2017
Can Focal Treatment Replace Radical Treatment in Prostate Cancer? For Focal Therapy
Scott Eggener
Reviews in Urology
|
February 22, 2019
Focal Therapy for Localized Prostate Cancer
Scott Eggener
Page
of 15
Search research articles
Search
Showing results (1-10 of 145) with videos related to
Sort By:
Page
of 15
The Journal of Urology
|
January 19, 2022
Editorial Comment
Scott Eggener
The Journal of Urology
|
February 22, 2011
Editorial comment
Scott Eggener
European Urology
|
September 19, 2015
Prostate Cancer Screening Biomarkers: An Emerging Embarrassment of 'Riches'?
Scott Eggener
Urologic Oncology
|
August 5, 2014
Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005
Scott Eggener
BJU International
|
January 22, 2015
How active should active surveillance be?
Scott Eggener
The Canadian Journal of Urology
|
June 19, 2012
Re: Active surveillance failure for prostate cancer: does the delay in treatment increase the risk of urinary incontinence?
Scott Eggener
European Urology
|
July 22, 2008
Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
Scott Eggener
European Urology Focus
|
July 21, 2017
Known Knowns, Known Unknowns, and Unknown Unknowns of High-intensity Focused Ultrasound for Prostate Cancer
Scott Eggener
European Urology Focus
|
November 28, 2017
Can Focal Treatment Replace Radical Treatment in Prostate Cancer? For Focal Therapy
Scott Eggener
Reviews in Urology
|
February 22, 2019
Focal Therapy for Localized Prostate Cancer
Scott Eggener
Page
of 15